Reuven Yeganeh insider trades

Open-market stock purchases and sales by Reuven Yeganeh, Director, 10% Owner at BiomX Inc, from SEC Form 4 filings since Dec 16, 2024.

Recent trades

DateStockTradeValue
Mar 17, 2026PHGE BiomX IncBought (not open market)$1.1M
Mar 17, 2026PHGE BiomX IncSold$2.6M
Mar 17, 2026PHGE BiomX IncBought (not open market)—
Mar 16, 2026PHGE BiomX IncBought (not open market)$900K
Mar 16, 2026PHGE BiomX IncSold$2.3M
Mar 16, 2026PHGE BiomX IncBought (not open market)—
Mar 16, 2026PHGE BiomX IncSold$6.5M
Mar 16, 2026PHGE BiomX IncSold$10.5M
Mar 16, 2026PHGE BiomX IncSold$8.1M
Mar 13, 2026PHGE BiomX IncBought (not open market)—
Mar 13, 2026PHGE BiomX IncBought (not open market)$740K
Mar 13, 2026PHGE BiomX IncSold$1.9M
Mar 12, 2026PHGE BiomX IncBought (not open market)—
Mar 12, 2026PHGE BiomX IncSold$1.5M
Mar 11, 2026PHGE BiomX IncBought (not open market)$600K
Nov 13, 2025NUKK Nukkleus IncBought (not open market)—

Companies traded

  • PHGE BiomX Inc: 7 sales, last Mar 17, 2026
  • NUKK Nukkleus Inc: other filings, last Nov 13, 2025

Get free alerts when Reuven Yeganeh files a new trade →